Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Vaccines

Free Subscription Articles published in Nat Immunol Retrieve available abstracts of 61 articles: HTML format

Single Articles

June 2024
1. 
   Vaccination prevents cognitive impairment after breakthrough infection with SARS-CoV-2.
   Nat Immunol. 2024 Jun 25. doi: 10.1038/s41590-024-01869.
   PubMed    
   
   
   
2. VANDERHEIDEN A, Hill JD, Jiang X, Deppen B, et al
   Vaccination reduces central nervous system IL-1beta and memory deficits after COVID-19 in mice.
   Nat Immunol. 2024 Jun 20. doi: 10.1038/s41590-024-01868.
   PubMed     Abstract available
   
   
   
3. SCHIFFNER T, Phung I, Ray R, Irimia A, et al
   Author Correction: Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
   Nat Immunol. 2024 Jun 14. doi: 10.1038/s41590-024-01891.
   PubMed    
   
   
   
4. RAY R, Schiffner T, Wang X, Yan Y, et al
   Affinity gaps among B cells in germinal centers drive the selection of MPER precursors.
   Nat Immunol. 2024;25:1083-1096.
   PubMed     Abstract available
   
   
   May 2024
5. SCHIFFNER T, Phung I, Ray R, Irimia A, et al
   Vaccination induces broadly neutralizing antibody precursors to HIV gp41.
   Nat Immunol. 2024 May 30. doi: 10.1038/s41590-024-01833.
   PubMed     Abstract available
   
   
   March 2024
6. FUMAGALLI V, Rava M, Marotta D, Di Lucia P, et al
   Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.
   Nat Immunol. 2024 Mar 14. doi: 10.1038/s41590-024-01787.
   PubMed     Abstract available
   
   
   
7. TRAN KA, Pernet E, Sadeghi M, Downey J, et al
   BCG immunization induces CX3CR1(hi) effector memory T cells to provide cross-protection via IFN-gamma-mediated trained immunity.
   Nat Immunol. 2024;25:418-431.
   PubMed     Abstract available
   
   
   February 2024
8. 
   A mechanism for BCG vaccine cross-protection against pulmonary viral infections.
   Nat Immunol. 2024 Feb 21. doi: 10.1038/s41590-024-01775.
   PubMed    
   
   
   
9. 
   A nasal vaccine elicits protective CD8(+) T cell immunity against antigen shifted SARS-CoV-2 virus.
   Nat Immunol. 2024 Feb 20. doi: 10.1038/s41590-024-01744.
   PubMed    
   
   
   
10. YING B, Darling TL, Desai P, Liang CY, et al
    Author Correction: Mucosal vaccine-induced cross-reactive CD8(+) T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
    Nat Immunol. 2024 Feb 15. doi: 10.1038/s41590-024-01781.
    PubMed    
    
    
    
11. YING B, Darling TL, Desai P, Liang CY, et al
    Mucosal vaccine-induced cross-reactive CD8(+) T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
    Nat Immunol. 2024 Feb 9. doi: 10.1038/s41590-024-01743.
    PubMed     Abstract available
    
    
    January 2024
12. 
    Building a next-generation, two-component protein subunit vaccine against monkeypox virus.
    Nat Immunol. 2024 Jan 18. doi: 10.1038/s41590-023-01735.
    PubMed    
    
    
    
13. 
    Baseline immune characteristics linked to pneumococcal vaccine responsiveness in older adults.
    Nat Immunol. 2024 Jan 5. doi: 10.1038/s41590-023-01737.
    PubMed    
    
    
    
14. RAVICHANDRAN S, Erra-Diaz F, Karakaslar OE, Marches R, et al
    Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults.
    Nat Immunol. 2024 Jan 5. doi: 10.1038/s41590-023-01717.
    PubMed     Abstract available
    
    
    
15. RESCIGNO M
    BCG-mediated viral protection goes biphasic.
    Nat Immunol. 2024;25:13-14.
    PubMed    
    
    
    December 2023
16. FORD ES, Mayer-Blackwell K, Jing L, Laing KJ, et al
    Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8(+) T cells in persons with previous COVID-19.
    Nat Immunol. 2023 Dec 6. doi: 10.1038/s41590-023-01692.
    PubMed     Abstract available
    
    
    November 2023
17. LEE A, Floyd K, Wu S, Fang Z, et al
    BCG vaccination stimulates integrated organ immunity by feedback of the adaptive immune response to imprint prolonged innate antiviral resistance.
    Nat Immunol. 2023 Nov 30. doi: 10.1038/s41590-023-01700.
    PubMed     Abstract available
    
    
    October 2023
18. MILLS KHG
    How immunology can help reverse the pertussis vaccine failure.
    Nat Immunol. 2023 Oct 2. doi: 10.1038/s41590-023-01625.
    PubMed    
    
    
    September 2023
19. PAINTER MM, Johnston TS, Lundgreen KA, Santos JJS, et al
    Prior vaccination promotes early activation of memory T cells and enhances immune responses during SARS-CoV-2 breakthrough infection.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01613.
    PubMed     Abstract available
    
    
    
20. ZHANG B, Upadhyay R, Hao Y, Samanovic MI, et al
    Multimodal single-cell datasets characterize antigen-specific CD8(+) T cells across SARS-CoV-2 vaccination and infection.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01608.
    PubMed     Abstract available
    
    
    
21. ANTOUN E, Peng Y, Dong T
    Vaccine-induced CD8(+) T cells are key to protection from SARS-CoV-2.
    Nat Immunol. 2023 Sep 21. doi: 10.1038/s41590-023-01621.
    PubMed    
    
    
    August 2023
22. HASSERT M, Harty JT
    Alt-RNAtive vaccines elicit anti-malarial T(RM) cells.
    Nat Immunol. 2023 Aug 14. doi: 10.1038/s41590-023-01594.
    PubMed    
    
    
    July 2023
23. GANLEY M, Holz LE, Minnell JJ, de Menezes MN, et al
    mRNA vaccine against malaria tailored for liver-resident memory T cells.
    Nat Immunol. 2023 Jul 20. doi: 10.1038/s41590-023-01562.
    PubMed     Abstract available
    
    
    June 2023
24. GAO GF
    Two-birds-one-stone approach to combine protein and mRNA vaccines for COVID-19.
    Nat Immunol. 2023 Jun 19. doi: 10.1038/s41590-023-01539.
    PubMed    
    
    
    
25. KAPLONEK P, Cizmeci D, Kwatra G, Izu A, et al
    ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19.
    Nat Immunol. 2023 Jun 15. doi: 10.1038/s41590-023-01513.
    PubMed     Abstract available
    
    
    
26. 
    Immunity to COVID after vaccination in First Nations peoples is affected by comorbidities.
    Nat Immunol. 2023;24:901-902.
    PubMed    
    
    
    
27. ZHANG W, Kedzierski L, Chua BY, Mayo M, et al
    Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities.
    Nat Immunol. 2023;24:966-978.
    PubMed     Abstract available
    
    
    May 2023
28. SILVA-CAYETANO A, Fra-Bido S, Robert PA, Innocentin S, et al
    Spatial dysregulation of T follicular helper cells impairs vaccine responses in aging.
    Nat Immunol. 2023 May 22. doi: 10.1038/s41590-023-01519.
    PubMed     Abstract available
    
    
    
29. JEYANATHAN M, Vaseghi-Shanjani M, Afkhami S, Grondin JA, et al
    Author Correction: Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis.
    Nat Immunol. 2023 May 9. doi: 10.1038/s41590-023-01525.
    PubMed    
    
    
    April 2023
30. VISAN I
    Primary vaccination imprint.
    Nat Immunol. 2023 Apr 24. doi: 10.1038/s41590-023-01515.
    PubMed    
    
    
    
31. NUNEZ NG, Schmid J, Power L, Alberti C, et al
    High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity.
    Nat Immunol. 2023 Apr 24. doi: 10.1038/s41590-023-01499.
    PubMed     Abstract available
    
    
    March 2023
32. VISAN I
    Vaccine-induced memory.
    Nat Immunol. 2023 Mar 23. doi: 10.1038/s41590-023-01489.
    PubMed    
    
    
    January 2023
33. 
    Lipid homeostasis mediated by cholesterol synthesis supports B cell responses to vaccination.
    Nat Immunol. 2023 Jan 6. doi: 10.1038/s41590-022-01400.
    PubMed    
    
    
    
34. HOUSTON S
    SARS-CoV-2 mucosal vaccine.
    Nat Immunol. 2023;24:1.
    PubMed    
    
    
    December 2022
35. PALIN AC, Alter G, Crotty S, Ellebedy AH, et al
    Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability.
    Nat Immunol. 2022 Dec 26. doi: 10.1038/s41590-022-01414.
    PubMed    
    
    
    
36. JEYANATHAN M, Vaseghi-Shanjani M, Afkhami S, Grondin JA, et al
    Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut-lung axis.
    Nat Immunol. 2022 Dec 1. doi: 10.1038/s41590-022-01354.
    PubMed     Abstract available
    
    
    
37. PALIN AC, Alter G, Crotty S, Ellebedy AH, et al
    The persistence of memory: defining, engineering, and measuring vaccine durability.
    Nat Immunol. 2022 Dec 1. doi: 10.1038/s41590-022-01359.
    PubMed    
    
    
    November 2022
38. PEDROZA-PACHECO I, McMichael AJ
    Immune signature atlas of vaccines: learning from the good responders.
    Nat Immunol. 2022 Nov 28. doi: 10.1038/s41590-022-01361.
    PubMed    
    
    
    October 2022
39. FOURATI S, Tomalin LE, Mule MP, Chawla DG, et al
    Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination.
    Nat Immunol. 2022 Oct 31. pii: 10.1038/s41590-022-01329.
    PubMed     Abstract available
    
    
    
40. HAGAN T, Gerritsen B, Tomalin LE, Fourati S, et al
    Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses.
    Nat Immunol. 2022 Oct 31. pii: 10.1038/s41590-022-01328.
    PubMed     Abstract available
    
    
    
41. QUAST I, Tarlinton D
    Time is of the essence for vaccine success.
    Nat Immunol. 2022 Oct 21. pii: 10.1038/s41590-022-01347.
    PubMed    
    
    
    September 2022
42. BRASU N, Elia I, Russo V, Montacchiesi G, et al
    Memory CD8(+) T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination.
    Nat Immunol. 2022 Sep 22. pii: 10.1038/s41590-022-01313.
    PubMed     Abstract available
    
    
    July 2022
43. HERATI RS, Knorr DA, Vella LA, Silva LV, et al
    PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01274.
    PubMed     Abstract available
    
    
    
44. KEDZIERSKA K, Nguyen THO
    PD-1 blockade unblocks immune responses to vaccination.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01254.
    PubMed    
    
    
    
45. YU D, Walker LSK, Liu Z, Linterman MA, et al
    Targeting TFH cells in human diseases and vaccination: rationale and practice.
    Nat Immunol. 2022 Jul 11. pii: 10.1038/s41590-022-01253.
    PubMed     Abstract available
    
    
    
46. QI H, Liu B, Wang X, Zhang L, et al
    The humoral response and antibodies against SARS-CoV-2 infection.
    Nat Immunol. 2022;23:1008-1020.
    PubMed     Abstract available
    
    
    May 2022
47. LUSTIG Y, Gonen T, Meltzer L, Gilboa M, et al
    Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
    Nat Immunol. 2022 May 9. pii: 10.1038/s41590-022-01212.
    PubMed     Abstract available
    
    
    March 2022
48. 
    IL-1-mediated inflammation induced by different RNA vaccines is context-specific.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01177.
    PubMed    
    
    
    
49. KOBIYAMA K, Ishii KJ
    Making innate sense of mRNA vaccine adjuvanticity.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01168.
    PubMed    
    
    
    
50. TAHTINEN S, Tong AJ, Himmels P, Oh J, et al
    IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
    Nat Immunol. 2022 Mar 24. pii: 10.1038/s41590-022-01160.
    PubMed     Abstract available
    
    
    
51. LI C, Lee A, Grigoryan L, Arunachalam PS, et al
    Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
    Nat Immunol. 2022 Mar 14. pii: 10.1038/s41590-022-01163.
    PubMed     Abstract available
    
    
    
52. MARTINEZ DR, Ooi EE
    A potential silver lining of delaying the second dose.
    Nat Immunol. 2022;23:349-351.
    PubMed    
    
    
    February 2022
53. TOMALKA JA, Suthar MS, Deeks SG, Sekaly RP, et al
    Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
    Nat Immunol. 2022 Feb 24. pii: 10.1038/s41590-022-01130.
    PubMed     Abstract available
    
    
    
54. HALL VG, Ferreira VH, Wood H, Ierullo M, et al
    Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses.
    Nat Immunol. 2022 Feb 3. pii: 10.1038/s41590-021-01126.
    PubMed     Abstract available
    
    
    January 2022
55. EGWANG TG, Owalla TJ, Kemigisha M
    COVID-19 vaccine trials must include helminth-infected cohorts.
    Nat Immunol. 2022 Jan 24. pii: 10.1038/s41590-021-01116.
    PubMed    
    
    
    
56. DOWELL AC, Butler MS, Jinks E, Tut G, et al
    Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
    Nat Immunol. 2022;23:40-49.
    PubMed     Abstract available
    
    
    December 2021
57. BERNARD NJ
    Vaccine thrombosis.
    Nat Immunol. 2021 Dec 22. pii: 10.1038/s41590-021-01111.
    PubMed    
    
    
    November 2021
58. BREWER RC, Ramadoss NS, Lahey LJ, Jahanbani S, et al
    BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
    Nat Immunol. 2021 Nov 30. pii: 10.1038/s41590-021-01088.
    PubMed     Abstract available
    
    
    
59. IRVINE EB, O'Neil A, Darrah PA, Shin S, et al
    Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Nat Immunol. 2021 Nov 22. pii: 10.1038/s41590-021-01066.
    PubMed     Abstract available
    
    
    
60. 
    NIAID workshop on secondary vaccine effects.
    Nat Immunol. 2021;22:1363-1366.
    PubMed    
    
    
    October 2021
61. CORBETT KS, Werner AP, Connell SO, Gagne M, et al
    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
    Nat Immunol. 2021;22:1306-1315.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.